EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SGLT2 inhibition induces autophagic flux blockade and sensitizes pancreatic cancer to EGFR-targeted therapy

Yuxin Wang, Enkui Zhang, Rui Ma, Weikang Liu, Qi Wang, Jun Zhang, Yinmo Yang, Yongsu Ma, Xiaodong Tian

Cellular Oncology · 2026

DOI: 10.1007/s13402-026-01256-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2026. Verfasst von Yuxin Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, 8th Xishiku Street, Beijing, 100034, People's Republic of China. Hauptthemen laut MEDLINE: Autophagy, Pancreatic Neoplasms, Sodium-Glucose Transporter 2, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyPancreatic NeoplasmsSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 InhibitorsCarcinoma, Pancreatic DuctalMolecular Targeted TherapyHumansAnimalsErbB ReceptorsCell Line, TumorApoptosisCell ProliferationSignal TransductionReactive Oxygen SpeciesXenograft Model Antitumor AssaysMice, NudeMiceAMP-Activated Protein KinasesCell Movement

Stichwörter der Autor:innen

AutophagyEGFR inhibitorGlucose metabolismPancreatic ductal adenocarcinomaSGLT2

Substanzen

ErbB ReceptorsSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 InhibitorsReactive Oxygen SpeciesAMP-Activated Protein KinasesEGFR protein, human

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, 8th Xishiku Street, Beijing, 100034, People's Republic of China.
  • Department of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, 8th Xishiku Street, Beijing, 100034, People's Republic of China. mayongsu@bjmu.edu.cn.
  • Department of Hepatobiliary and Pancreatic Surgery, Peking University First Hospital, 8th Xishiku Street, Beijing, 100034, People's Republic of China. tianxiaodong@pkufh.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Wang, Y., Zhang, E., Ma, R., Liu, W., Wang, Q., Zhang, J., Yang, Y., Ma, Y., & Tian, X. (2026). SGLT2 inhibition induces autophagic flux blockade and sensitizes pancreatic cancer to EGFR-targeted therapy. Cellular Oncology. https://doi.org/10.1007/s13402-026-01256-9

Vancouver

Wang Y, Zhang E, Ma R, Liu W, Wang Q, Zhang J, et al. SGLT2 inhibition induces autophagic flux blockade and sensitizes pancreatic cancer to EGFR-targeted therapy. Cellular Oncology. 2026. doi:10.1007/s13402-026-01256-9

BibTeX
@article{Wang2026,
  author = {Wang, Yuxin and Zhang, Enkui and Ma, Rui and Liu, Weikang and Wang, Qi and Zhang, Jun and Yang, Yinmo and Ma, Yongsu and Tian, Xiaodong},
  title = {SGLT2 inhibition induces autophagic flux blockade and sensitizes pancreatic cancer to EGFR-targeted therapy},
  journal = {Cellular Oncology},
  year = {2026},
  doi = {10.1007/s13402-026-01256-9}
}
Kostenlos starten →